Guidance on the use of probiotics in clinical practice in children with selected clinical conditions and in specific vulnerable groups

Creative Commons License

Hojsak I., Fabiano V., Pop T. L., Goulet O., Zuccotti G. V., Cokugras F. C., ...More

ACTA PAEDIATRICA, vol.107, no.6, pp.927-937, 2018 (SCI-Expanded, Scopus) identifier identifier identifier

  • Publication Type: Article / Review
  • Volume: 107 Issue: 6
  • Publication Date: 2018
  • Doi Number: 10.1111/apa.14270
  • Journal Name: ACTA PAEDIATRICA
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.927-937
  • Keywords: Bifidobacterium, Children, Lactobacillus, Probiotics, Saccharomyces, INTERNATIONAL SCIENTIFIC ASSOCIATION, LACTOBACILLUS-RHAMNOSUS HN001, REUTERI DSM 17938, 1ST 6 MONTHS, DOUBLE-BLIND, PRIMARY PREVENTION, NOSOCOMIAL DIARRHEA, FOLLOW-UP, CONSENSUS STATEMENT, ALLERGIC DISEASE
  • Open Archive Collection: AVESIS Open Access Collection
  • Istanbul University-Cerrahpasa Affiliated: Yes

Abstract

Aim: The use of probiotics has been covered by many guidelines, position papers and evidence-based recommendations, but few have referred to specific patient groups or clinical indications. This review summarises recommendations and scientifically credited guidelines on the use of probiotics for children with selected clinical conditions and provides practice points.